Carrier Screening Market

Carrier Screening Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

168

Base Year:

2022

Jan - 2022

Format:

Report Code:

VMR-1131

Segments Covered

By Type Expanded Carrier Screening, Targeted Disease Carrier Screening
By Technology DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others
By End User Hospitals & Clinics, Reference Laboratories, Physician Offices, Others
By Regions North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 2.34 Billion
Revenue 2030:	USD 8.27 Billion
Revenue CAGR (2023 - 2030):	17.10%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Carrier Screening Market - Segment Analysis
1. Overview
2. Global Carrier Screening Market, 2016 - 2028 (USD Million)
3. Global Carrier Screening Market - by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. Global Carrier Screening Market - by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. Global Carrier Screening Market - by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. Global Carrier Screening Market - by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. Global Carrier Screening Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Carrier Screening Market - Segment Analysis
1. Overview
2. North America Carrier Screening Market, 2016 - 2028 (USD Million)
3. North America Carrier Screening Market, by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. North America Carrier Screening Market, by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. North America Carrier Screening Market, by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. North America Carrier Screening Market, by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. North America Carrier Screening Market, by Country
  1. U.S.
    1. U.S. Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. U.S. Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. U.S. Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. U.S. Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  2. Canada
    1. Canada Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Canada Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Canada Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Canada Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  3. Mexico
    1. Mexico Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Mexico Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Mexico Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Mexico Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
Europe Carrier Screening Market - Segment Analysis
1. Overview
2. Europe Carrier Screening Market, 2016 - 2028 (USD Million)
3. Europe Carrier Screening Market, by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. Europe Carrier Screening Market, by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. Europe Carrier Screening Market, by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. Europe Carrier Screening Market, by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. Europe Carrier Screening Market, by Country
  1. Germany
    1. Germany Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Germany Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Germany Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Germany Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  2. UK
    1. UK Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. UK Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. UK Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. UK Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  3. France
    1. France Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. France Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. France Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. France Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  4. Spain
    1. Spain Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Spain Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Spain Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Spain Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  5. Italy
    1. Italy Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Italy Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Italy Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Italy Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  6. BENELUX
    1. BENELUX Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. BENELUX Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. BENELUX Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. BENELUX Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  7. Rest of Europe
    1. Rest Of Europe Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Rest Of Europe Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Rest Of Europe Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Rest Of Europe Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
Asia Pacific Carrier Screening Market - Segment Analysis
1. Overview
2. Asia Pacific Carrier Screening Market, 2016 - 2028 (USD Million)
3. Asia Pacific Carrier Screening Market, by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. Asia Pacific Carrier Screening Market, by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. Asia Pacific Carrier Screening Market, by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. Asia Pacific Carrier Screening Market, by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. Asia Pacific Carrier Screening Market, by Country
  1. China
    1. China Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. China Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. China Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. China Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  2. Japan
    1. Japan Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Japan Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Japan Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Japan Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  3. India
    1. India Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. India Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. India Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. India Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  4. South Korea
    1. South Korea Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. South Korea Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. South Korea Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. South Korea Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  5. South East Asia
    1. South East Asia Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. South East Asia Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. South East Asia Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. South East Asia Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Rest of Asia Pacific Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Rest of Asia Pacific Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Rest of Asia Pacific Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
Latin America Carrier Screening Market - Segment Analysis
1. Overview
2. Latin America Carrier Screening Market, 2016 - 2028 (USD Million)
3. Latin America Carrier Screening Market, by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. Latin America Carrier Screening Market, by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. Latin America Carrier Screening Market, by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. Latin America Carrier Screening Market, by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. Latin America Carrier Screening Market, by Country
  1. Brazil
    1. Brazil Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Brazil Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Brazil Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Brazil Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  2. Argentina
    1. Argentina Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Argentina Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Argentina Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Argentina Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  3. Rest of Latin America
    1. Rest of Latin America Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Rest of Latin America Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Rest of Latin America Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Rest of Latin America Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
Middle East & Africa Carrier Screening Market - Segment Analysis
1. Overview
2. Middle East & Africa Carrier Screening Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Carrier Screening Market, by Type
  1. By Expanded Carrier Screening
  2. By Targeted Disease Carrier Screening
4. Middle East & Africa Carrier Screening Market, by Technology
  1. By DNA Sequencing
  2. By Polymerase Chain Reaction
  3. By Microarrays
  4. By Others
5. Middle East & Africa Carrier Screening Market, by End User
  1. By Hospitals & Clinics
  2. By Reference Laboratories
  3. By Physician Offices
  4. By Others
6. Middle East & Africa Carrier Screening Market, by Regions
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Middle East & Africa
  5. By Latin America
7. Middle East & Africa Carrier Screening Market, by Country
  1. GCC Countries
    1. GCC Countries Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. GCC Countries Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. GCC Countries Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. GCC Countries Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  2. South Africa
    1. South Africa Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. South Africa Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. South Africa Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. South Africa Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Carrier Screening Market, By Type
      1. By Expanded Carrier Screening
      2. By Targeted Disease Carrier Screening
    2. Rest of Middle East & Africa Carrier Screening Market, By Technology
      1. By DNA Sequencing
      2. By Polymerase Chain Reaction
      3. By Microarrays
      4. By Others
    3. Rest of Middle East & Africa Carrier Screening Market, By End User
      1. By Hospitals & Clinics
      2. By Reference Laboratories
      3. By Physician Offices
      4. By Others
    4. Rest of Middle East & Africa Carrier Screening Market, By Regions
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Middle East & Africa
      5. By Latin America
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Invitae (US)
2. Eurofins Scientific (US)
3. Fulgent Genetics (US)
4. OPKO Health (US)
5. Quest Diagnostics (US)
6. Myriad Genetics (US)
7. Sema4 (US)
8. Thermo Fisher Scientific (US) and Illumina (US)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Carrier Screening in terms of revenue?

The global Carrier Screening valued at USD 2.34 Billion in 2022 and is expected to reach USD 8.27 Billion in 2030 growing at a CAGR of 17.10%.

Which are the prominent players in the market?

The prominent players in the market are Invitae (US), Eurofins Scientific (US), Fulgent Genetics (US), OPKO Health (US), Quest Diagnostics (US), Myriad Genetics (US), Sema4 (US), Thermo Fisher Scientific (US) and Illumina (US).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 17.10% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Carrier Screening include
- Recent Development in Carrier Screening is Playing Key Role in Development of Carrier Screening Market

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Carrier Screening in 2022.

Carrier Screening Market

Carrier Screening Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Carrier Screening in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Carrier Screening Market

Carrier Screening Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Carrier Screening in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Carrier Screening Market

Vantage Point Interactive Dashboard